AASLD guidelines for the treatment of hepatocellular carcinoma

K. Heimbach, Julie; Kulik, Laura; S. Finn, Richard; B. Sirlin, Claude; Abécassis, Michaël; R. Roberts, Lewis; X. Zhu, Andrew; Hassan Murad, M.; A. Marrero, Jorge

doi:10.1002/hep.29086

Public

AASLD guidelines for the treatment of hepatocellular carcinoma

Published in Hepatology • Jan 28, 2017

Authors:

Julie K. Heimbach

Laura Kulik

Richard S. Finn

Abstract

Potential conflict of interest: Laura M. Kulik is on the advisory board for Gilead, Bayer, Eisai, Salix, and Bristol‐Myers Squibb. Richard Finn consults for Pfizer, Bayer, Novartis, Merck, and Bristol‐Myers Squibb. Claude B. Sirlin consults for and has received grants from Virtualscopics. Lewis R. R...

Subject

Hepatocellular carcinoma

Medicine

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!